You have 9 free searches left this month | for more free features.

hmpl-689

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed/Refractory Lymphoma Trial in Shanghai (tazemetostat, HMPL-689)

Not yet recruiting
  • Relapsed/Refractory Lymphoma
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Feb 2, 2023

Lymphomas Trial in Wuhan, Guangzhou, Shanghai (HMPL-689)

Active, not recruiting
  • Lymphomas
  • HMPL-689
  • Wuhan, Hubei, China
  • +2 more
Sep 8, 2022

Lymphoma Trial in Worldwide (HMPL-689)

Active, not recruiting
  • Lymphoma
  • HMPL-689
  • Anaheim, California
  • +26 more
Jan 11, 2023

Marginal Zone Lymphoma, Follicular Lymphoma Trial in China (HMPL-689)

Recruiting
  • Marginal Zone Lymphoma
  • Follicular Lymphoma
  • HMPL-689
  • Hefei, Anhui, China
  • +35 more
Jun 7, 2021

Healthy Volunteers Trial in Melbourne (HMPL-689, HMPL-689 )

Completed
  • Healthy Volunteers
  • HMPL-689
  • HMPL-689 placebo
  • Melbourne, Victoria, Australia
    Nucleus Network
Aug 15, 2017